About this event

  • Date and time Mon 17 Jun 2019 from 10:00am to 7:20pm
  • Location Royal Society of Medicine
  • Organised by Oncology

This meeting will focus on the latest updates on the scientific, clinical, and psychosocial aspects of breast cancer in young woman and the multi-disciplinary management of these cases, considering that the patients are at the peak of their careers, social life and reproductive years.

Understand how to advise on supportive care and survivorship issues, including fertility, menopausal concerns, body image, sexual functioning, genetic risk, and psychological health.


We would like to thank our exhibitor(s):
Roche, Pfizer, Eisai, Novartis and Green Distribution Ltd
Please note that none of the companies listed have had any influence or involvement over the agenda, content or organisation of this meeting.

Key speakers

Dr Ann H. Partridge

Dr Ann H. Partridge

Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute

Speaker's biography

Dr. Partridge's research focuses on psychosocial and medical outcomes of patients with cancer with a particular focus on young women with breast cancer and cancer survivorship issues. Current projects include a large prospective cohort study of young women with breast cancer, a randomized trial evaluating the efficacy of an educational and supportive care program for young women with breast cancer, evaluations of age, race and outcomes in breast cancer survivors, decision-making and quality of life in a large cooperative group breast cancer trial, and studies to improve understanding of and optimize cancer survivorship care.


View the programme

Registration, tea and coffee
Welcome and introduction

Professor Ian Smith, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust

My Journey

Professor Ian Smith and Dr Bhawna Sirohi, President, Oncology Section, The Royal Society of Medicine and Director, Medical Oncology, Max Institute of Cancer Care, New Delhi

My Journey

Dr Olar Adeyi

Session 1: Leah Ledermann Lecture

Professor Ian Smith

Breast Cancer in young women: Understanding differences to improve outcomes

Dr Ann H Partridge, Vice Chair of Medical Oncology, Dana-Farber Cancer Institute, Director, Program for Young Women with Breast Cancer and Director, Adult Survivorship Program

Panel discussion

Session 2: Managing effects of cancer treatment

Dr Anne Armstrong, Chair, National Cancer Research Institute Symptom Management Group, Christies, Manchester and Dr Judy King, Consultant Medical Oncologist, Royal Free Hospital NHS Foundation Trust

Fertility and planning a family

Dr Stuart Lavery, Consultant in Gynaecology, Reproductive Medicine and Surgery, Hammersmith Hospital

Menopausal symptoms

Dr Anne Armstrong

Managing the sexual consequences of breast cancer

Dr. Isabel White, Clinical Nursing Research Fellow in Psychosexual Practice, The Royal Marsden NHS Foundation Trust

Panel discussion

Ms Jo Taylor, Founder, After Breast Cancer Diagnosis, Dr Stuart Lavery, Dr Isobel White, Dr Anne Armstrong and Dr Fharat Raja, Consultant Medical Oncologist, University College London Hospitals

Section member annual general meeting

Session 3: Controversies

Professor Stephen Johnston, Professor Stephen Johnston, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust and Dr Ann Partridge

Complexities of surgery in young women

Mr Henry Cain, Consultant Oncoplastic Breast Surgeon, Royal Victoria Infirmary, Newcastle Hospitals NHS Foundation Trust

Can we select young women with breast cancer who do not need chemotherapy?

Professor Stephen Johnston

Bisphosphonates in young women with breast cancer – who should not receive it?

Professor Robert Coleman, Emeritus Professor of Medical Oncology, University of Sheffield

Debate: Tumour profiling should be offered to all patients with advanced breast cancer

For: Dr Mark Verrill, Head of the Department of Medical Oncology, Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne


Against: Professor Nic Turner, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust

Tea and coffee break

Session 4: Social Media / Advocacy

Dr Susannah Stanway, Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust and Professor Ian Smith

Social media and patient care

Dr Richard Simcock, Consultant Clinical Oncologist, Sussex Cancer Centre, Brighton

MCBS / young women with breast cancer – choosing wisely in oncology

Professor Richard Sullivan, Professor of Cancer and Global Health, Kings College London

Panel discussion

Dr Richard Simcock, Dr Susannah Stanway, Dr Ann Partridge, Dame Delyth Morgan, Chief Executive, Breast Cancer Now, Dr Olar Adeyi, Patient Advocate and Ms Nicola Cunningham, Manager, Breast Cancer Haven, London

Closing remarks

Dr Bhawna Sirohi

Sylvia Lawler prize

Drinks reception

Poster viewing for Sylvia Lawler prize

Sylvia Lawler Prize oral presentations
Award of prize



Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

Other events

OCN01 Promo

Cancer control in low and middle income countries: New solutions to evolving challenges

Join us for the 4th year of this important meeting, where a faculty of prominent speakers from around the globe will discuss the importance of effective cancer control in low and middle-income countries (LMIC) and highlight the magnitude of the disparities and issues that currently exist. 

  • Price £40 - £150
  • Location Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom